Literature DB >> 24778441

Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.

Nicholas M Provine1, Rafael A Larocca1, Pablo Penaloza-MacMaster1, Erica N Borducchi1, Anna McNally1, Lily R Parenteau1, David R Kaufman1, Dan H Barouch2.   

Abstract

Despite the widespread use of replication-incompetent recombinant adenovirus (Ad) vectors as candidate vaccine platforms, the mechanism by which these vectors elicit CD8(+) T cell responses remains poorly understood. Our data demonstrate that induction and maintenance of CD8(+) T cell responses by Ad vector immunization is longitudinally dependent on CD4(+) T cell help for a prolonged period. Depletion of CD4(+) T cells in wild type mice within the first 8 d following Ad immunization resulted in dramatically reduced induction of Ag-specific CD8(+) T cells, decreased T-bet and eomesodermin expression, impaired KLRG1(+) effector differentiation, and atypical expression of the memory markers CD127, CD27, and CD62L. Moreover, these CD8(+) T cells failed to protect against a lethal recombinant Listeria monocytogenes challenge. Depletion of CD4(+) T cells between weeks 1 and 4 following immunization resulted in increased contraction of memory CD8(+) T cells. These data demonstrate a prolonged temporal requirement for CD4(+) T cell help for vaccine-elicited CD8(+) T cell responses in mice. These findings have important implications in the design of vaccines aimed at eliciting CD8(+) T cell responses and may provide insight into the impaired immunogenicity of vaccines in the context of AIDS and other CD4(+) T cell immune deficiencies.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24778441      PMCID: PMC4025612          DOI: 10.4049/jimmunol.1302806

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.

Authors:  K Chan; D J Lee; A Schubert; C M Tang; B Crain; S P Schoenberger; M Corr
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

3.  CD27 is required for generation and long-term maintenance of T cell immunity.

Authors:  J Hendriks; L A Gravestein; K Tesselaar; R A van Lier; T N Schumacher; J Borst
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

4.  Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses.

Authors:  Kathryn E Foulds; Lauren A Zenewicz; Devon J Shedlock; Jiu Jiang; Amy E Troy; Hao Shen
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

5.  Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells.

Authors:  Hirohito Ichii; Akemi Sakamoto; Masahiko Hatano; Seiji Okada; Hirochika Toyama; Shinsuke Taki; Masafumi Arima; Yoshikazu Kuroda; Takeshi Tokuhisa
Journal:  Nat Immunol       Date:  2002-05-20       Impact factor: 25.606

6.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Authors:  John W Shiver; Tong-Ming Fu; Ling Chen; Danilo R Casimiro; Mary-Ellen Davies; Robert K Evans; Zhi-Qiang Zhang; Adam J Simon; Wendy L Trigona; Sheri A Dubey; Lingyi Huang; Virginia A Harris; Romnie S Long; Xiaoping Liang; Larry Handt; William A Schleif; Lan Zhu; Daniel C Freed; Natasha V Persaud; Liming Guan; Kara S Punt; Aimin Tang; Minchun Chen; Keith A Wilson; Kelly B Collins; Gwendolyn J Heidecker; V Rose Fernandez; Helen C Perry; Joseph G Joyce; Karen M Grimm; James C Cook; Paul M Keller; Denise S Kresock; Henryk Mach; Robert D Troutman; Lynne A Isopi; Donna M Williams; Zheng Xu; Kathryn E Bohannon; David B Volkin; David C Montefiori; Ayako Miura; Georgia R Krivulka; Michelle A Lifton; Marcelo J Kuroda; Jörn E Schmitz; Norman L Letvin; Michael J Caulfield; Andrew J Bett; Rima Youil; David C Kaslow; Emilio A Emini
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

7.  Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.

Authors:  X Ye; M B Robinson; C Pabin; M L Batshaw; J M Wilson
Journal:  Gene Ther       Date:  2000-10       Impact factor: 5.250

8.  First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).

Authors:  Lindsey R Baden; Stephen R Walsh; Michael S Seaman; Robert P Tucker; Kathleen H Krause; Alka Patel; Jennifer A Johnson; Jane Kleinjan; Katherine E Yanosick; James Perry; Elise Zablowsky; Peter Abbink; Lauren Peter; M Justin Iampietro; Ann Cheung; Maria G Pau; Mo Weijtens; Jaap Goudsmit; Edith Swann; Mark Wolff; Hayley Loblein; Raphael Dolin; Dan H Barouch
Journal:  J Infect Dis       Date:  2012-11-02       Impact factor: 5.226

9.  Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

Authors:  Dan H Barouch; Jinyan Liu; Lauren Peter; Peter Abbink; M Justin Iampietro; Ann Cheung; Galit Alter; Amy Chung; Anne-Sophie Dugast; Nicole Frahm; M Juliana McElrath; Holger Wenschuh; Ulf Reimer; Michael S Seaman; Maria G Pau; Mo Weijtens; Jaap Goudsmit; Stephen R Walsh; Raphael Dolin; Lindsey R Baden
Journal:  J Infect Dis       Date:  2012-11-02       Impact factor: 5.226

Review 10.  Transcriptional control of effector and memory CD8+ T cell differentiation.

Authors:  Susan M Kaech; Weiguo Cui
Journal:  Nat Rev Immunol       Date:  2012-10-19       Impact factor: 53.106

View more
  20 in total

1.  Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice.

Authors:  Junghwa Lee; Masao Hashimoto; Se Jin Im; Koichi Araki; Hyun-Tak Jin; Carl W Davis; Bogumila T Konieczny; Gregory A Spies; M Juliana McElrath; Rafi Ahmed
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

2.  Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function.

Authors:  Rafael A Larocca; Nicholas M Provine; Malika Aid; M Justin Iampietro; Erica N Borducchi; Alexander Badamchi-Zadeh; Peter Abbink; David Ng'ang'a; Christine A Bricault; Eryn Blass; Pablo Penaloza-MacMaster; Kathryn E Stephenson; Dan H Barouch
Journal:  Sci Immunol       Date:  2016-11-04

3.  A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.

Authors:  Monica Cabrera-Mora; Jairo Andres Fonseca; Balwan Singh; Chunxia Zhao; Natalia Makarova; Igor Dmitriev; David T Curiel; Jerry Blackwell; Alberto Moreno
Journal:  J Immunol       Date:  2016-08-29       Impact factor: 5.422

4.  Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Authors:  Nicholas M Provine; Rafael A Larocca; Malika Aid; Pablo Penaloza-MacMaster; Alexander Badamchi-Zadeh; Erica N Borducchi; Kathleen B Yates; Peter Abbink; Marinela Kirilova; David Ng'ang'a; Jonathan Bramson; W Nicholas Haining; Dan H Barouch
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

5.  Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins.

Authors:  Nicolas Çuburu; Selina Khan; Cynthia D Thompson; Rina Kim; Jort Vellinga; Roland Zahn; Douglas R Lowy; Gert Scheper; John T Schiller
Journal:  Int J Cancer       Date:  2017-12-01       Impact factor: 7.396

6.  MAIT cell activation augments adenovirus vector vaccine immunogenicity.

Authors:  Nicholas M Provine; Ali Amini; Lucy C Garner; Alexandra J Spencer; Christina Dold; Claire Hutchings; Laura Silva Reyes; Michael E B FitzPatrick; Senthil Chinnakannan; Blanche Oguti; Meriel Raymond; Marta Ulaszewska; Fulvia Troise; Hannah Sharpe; Sophie B Morgan; Timothy S C Hinks; Teresa Lambe; Stefania Capone; Antonella Folgori; Eleanor Barnes; Christine S Rollier; Andrew J Pollard; Paul Klenerman
Journal:  Science       Date:  2021-01-29       Impact factor: 47.728

7.  Distinct CD4 T-cell effects on primary versus recall CD8 T-cell responses during viral encephalomyelitis.

Authors:  Mihyun Hwang; Timothy W Phares; David R Hinton; Stephen A Stohlman; Cornelia C Bergmann; Booki Min
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

8.  Transient CD4+ T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses.

Authors:  Nicholas M Provine; Alexander Badamchi-Zadeh; Christine A Bricault; Pablo Penaloza-MacMaster; Rafael A Larocca; Erica N Borducchi; Michael S Seaman; Dan H Barouch
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

9.  Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.

Authors:  Meike Kaulfuß; Ina Wensing; Sonja Windmann; Camilla Patrizia Hrycak; Wibke Bayer
Journal:  Retrovirology       Date:  2017-02-06       Impact factor: 4.602

10.  Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites.

Authors:  Kimberly A Hofmeyer; Malcolm S Duthie; John D Laurance; Michelle A Favila; Neal Van Hoeven; Rhea N Coler; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.